I am an anaesthestist for 40 years and 99 % of surgeons will do everything for their patients outcome despite their personal personalities. A total knee replacement costs $30,000 so the heart surgeon will spend $2000 for an adapt artery product to get a good outcome for his or her patient if the patients donor leg vein graft is unsuitable for coronary grafting. If in doubt do you use it or go for Admedus adapt VC ?
We are heading for a brand market so lets go for a premium price in due course.
- Forums
- ASX - By Stock
- AVR
- "Take a Closer Look"
"Take a Closer Look", page-651
-
- There are more pages in this discussion • 577 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.00 |
Change
0.150(1.01%) |
Mkt cap ! $317.0M |
Open | High | Low | Value | Volume |
$15.00 | $15.15 | $14.30 | $210.2K | 14.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $14.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 5153 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 92 | 15.200 |
1 | 60 | 14.350 |
1 | 38 | 14.260 |
1 | 200 | 14.200 |
1 | 65 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 5143 | 3 |
15.150 | 204 | 1 |
15.500 | 44 | 1 |
16.030 | 999 | 1 |
16.500 | 971 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online